Chronic Venous Insufficiency Case Study
Patient Presentation
A 62-year-old woman presents with a 3-year history of progressive bilateral lower extremity swelling, aching pain that worsens with prolonged standing, and visible tortuous veins on both legs. She works as a retail manager, standing 8-10 hours daily. Her past medical history includes two pregnancies and a BMI of 32. Six months ago, she developed brownish discoloration around her left medial ankle with mild skin thickening. She reports her symptoms significantly limit her ability to work and exercise.
Clinical Classification
This patient presents with CEAP classification C4b disease (lipodermatosclerosis and skin changes) with bilateral great saphenous vein insufficiency. 1 The CEAP system categorizes severity from C0 (no visible signs) through C6 (active ulceration), with this patient's skin changes indicating advanced disease requiring intervention beyond conservative management alone. 1
Initial Diagnostic Approach
Duplex ultrasound of the lower extremities is the mandatory first-line diagnostic test. 1 The examination must evaluate:
- Deep venous system patency to exclude post-thrombotic syndrome 1
- Great saphenous vein (GSV) and small saphenous vein (SSV) for reflux >500 milliseconds 1
- Perforating veins near areas of skin changes 1
- Accessory saphenous veins and alternative reflux pathways 1
The ultrasound should be performed with the patient standing on one leg or positioned at 60 degrees if standing is not tolerated. 1 Reflux is defined as retrograde flow exceeding 500 milliseconds, typically resulting from primary valve degeneration or prior deep vein thrombosis. 1
Advanced imaging with CT or MR venography is reserved only for cases where ultrasound is technically limited (severe obesity) or when anatomic variants need characterization before intervention. 1 These are not first-line tests.
Treatment Algorithm
Step 1: Compression Therapy (Initial Management)
For this C4b patient, initiate 30-40 mm Hg compression therapy immediately. 1 This pressure range is specifically recommended for more severe disease (C4-C6), while 20-30 mm Hg suffices for milder presentations. 1
Critical technical point: Apply negative graduated compression with higher pressure at the calf rather than the ankle. 1 This technique achieves superior ejection fraction in refluxing vessels compared to traditional graduated compression (higher pressure at ankle). 1
Important caveat: While compression has proven efficacy for C5 (preventing ulcer recurrence) and C6 disease (healing active ulcers), evidence for quality of life improvement in C2-C4 disease relies primarily on surrogate outcomes. 1 However, compression remains first-line therapy and should be attempted for 3-6 months before proceeding to invasive interventions. 1
Step 2: Saphenous Vein Ablation (Definitive Treatment)
If symptoms persist despite adequate compression therapy, proceed with endovenous ablation of the incompetent saphenous vein. 1 Both radiofrequency ablation (RFA) and endovenous laser ablation (EVLA) have largely replaced surgical stripping due to:
- Equivalent or superior efficacy compared to surgery 1
- Improved early quality of life 1
- Reduced complications including fewer bleeding, hematoma, wound infections, and paresthesia rates 1
- Shorter hospital recovery time 1
The choice between RFA and EVLA is equivalent—both use tumescent anesthesia and achieve vein obliteration through thermal energy. 1 Select based on operator experience and equipment availability.
Step 3: Adjunctive Procedures
For visible varicosities not addressed by saphenous ablation, add compression sclerotherapy or microphlebectomy. 1 These procedures are complementary and often performed simultaneously to address branch varicosities and residual incompetent veins. 1
Follow-Up Monitoring
Perform repeat duplex ultrasound if symptoms recur or skin changes progress. 1 Assess for:
- Recanalization of treated saphenous vein (occurs in 15-35% at 2 years) 1
- Reflux into Giacomini vein transmitting to small saphenous vein 1
- New perforator incompetence 1
Check ankle-brachial index if ulceration develops, as 16% of venous ulcer patients have unrecognized arterial disease requiring different management. 1
Critical Pitfalls to Avoid
Never apply compression >20-30 mm Hg if ankle-brachial index is 0.6-0.9, and avoid compression entirely if <0.6 (indicates arterial insufficiency requiring revascularization first). 1 This is a critical safety consideration that prevents tissue ischemia.
Do not rely solely on compression for C4b disease expecting quality of life improvement—the evidence is weak for symptomatic benefit in C2-C4 disease despite widespread historical acceptance. 1 Proceed to ablation if symptoms significantly impact function after a reasonable compression trial.
Ensure proper compression fitting and patient education—historically, treatment failure was attributed to noncompliance, but systematic reviews show the evidence for compression alone is inadequate for C2-C4 disease. 1 Set realistic expectations about symptom improvement.
Expected Outcomes
With combined compression and saphenous ablation, expect significant improvement in pain, swelling, and skin changes within 3-6 months. 1 The recurrence rate at 2 years is 15-35%, necessitating ongoing surveillance. 1 Patients with C4b disease who progress to ulceration (C6) face treatment costs exceeding $2.5 billion annually in the US, emphasizing the importance of early definitive intervention. 1